GLOBAL NASAL SPRAY MARKET 2021-2028

 

 TABLE OF CONTENTS

 

1.     GLOBAL NASAL SPRAY MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON NASAL SPRAY MARKET

2.2. KEY INSIGHTS

2.2.1.    ALLERGY TREATMENTS WITH NASAL SPRAYS

2.2.2.    UTILIZING NASAL SPRAY FOR DIABETES

2.2.3.    ENDOMETRIOSIS TREATMENT WITH NASAL SPRAYS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1.    MERGERS & ACQUISITIONS

2.6.2.    CONTRACTS & AGREEMENTS

2.6.3.    DIVESTITURES

2.7. MARKET DRIVERS

2.7.1.    EMERGING INTRANASAL VACCINES FOR COVID-19

2.7.2.    INCREASING ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION

2.7.3.    GROWING USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES

2.8. MARKET CHALLENGES

2.8.1.    COMPLICATIONS DUE TO EXCESS USE OF NASAL SPRAYS

2.9. MARKET OPPORTUNITIES

2.9.1.    APPLICATION OF NASAL SPRAYS IN TREATING DEPRESSION

2.9.2.    USING INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS

2.9.3.    EMPLOYING NASAL SPRAY AS A VACCINE

3.     GLOBAL NASAL SPRAY MARKET OUTLOOK - BY TYPE

3.1. DECONGESTION NASAL SPRAY

3.2. STEROID NASAL SPRAY

3.3. SALTWATER SOLUTION/SALINE NASAL SPRAY

4.     GLOBAL NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION

4.1. OVER-THE-COUNTER

4.2. PRESCRIBED

5.     GLOBAL NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC

5.1. ANTIHISTAMINE

5.2. NASAL STEROIDS

5.3. ANTICHOLINERGIC

5.4. MAST CELL INHIBITOR

6.     GLOBAL NASAL SPRAY MARKET OUTLOOK - BY APPLICATION

6.1. NASAL CONGESTION

6.2. ALLERGIC AND NON-ALLERGIC RHINITIS

6.3. VACCINATION

6.4. CNS DISORDERS

6.5. OTHER APPLICATIONS

7.     GLOBAL NASAL SPRAY MARKET OUTLOOK - BY END-USER

7.1. HOME CARE SETTING

7.2. ASC/CLINICS

7.3. PHARMACY

7.4. HOSPITAL

7.5. OTHER END-USERS

8.     GLOBAL NASAL SPRAY MARKET – REGIONAL OUTLOOK

8.1. NORTH AMERICA

8.1.1.    MARKET BY TYPE

8.1.2.    MARKET BY PRESCRIPTION

8.1.3.    MARKET BY THERAPEUTIC

8.1.4.    MARKET BY APPLICATION

8.1.5.    MARKET BY END-USER

8.1.6.    COUNTRY ANALYSIS

8.1.6.1.        UNITED STATES

8.1.6.2.        CANADA

8.2. EUROPE

8.2.1.    MARKET BY TYPE

8.2.2.    MARKET BY PRESCRIPTION

8.2.3.    MARKET BY THERAPEUTIC

8.2.4.    MARKET BY APPLICATION

8.2.5.    MARKET BY END-USER

8.2.6.    COUNTRY ANALYSIS

8.2.6.1.        UNITED KINGDOM

8.2.6.2.        GERMANY

8.2.6.3.        FRANCE

8.2.6.4.        SPAIN

8.2.6.5.        ITALY

8.2.6.6.        RUSSIA

8.2.6.7.        REST OF EUROPE

8.3. ASIA-PACIFIC

8.3.1.    MARKET BY TYPE

8.3.2.    MARKET BY PRESCRIPTION

8.3.3.    MARKET BY THERAPEUTIC

8.3.4.    MARKET BY APPLICATION

8.3.5.    MARKET BY END-USER

8.3.6.    COUNTRY ANALYSIS

8.3.6.1.        CHINA

8.3.6.2.        JAPAN

8.3.6.3.        INDIA

8.3.6.4.        SOUTH KOREA

8.3.6.5.        ASEAN COUNTRIES

8.3.6.6.        AUSTRALIA & NEW ZEALAND

8.3.6.7.        REST OF ASIA-PACIFIC

8.4. LATIN AMERICA

8.4.1.    MARKET BY TYPE

8.4.2.    MARKET BY PRESCRIPTION

8.4.3.    MARKET BY THERAPEUTIC

8.4.4.    MARKET BY APPLICATION

8.4.5.    MARKET BY END-USER

8.4.6.    COUNTRY ANALYSIS

8.4.6.1.        BRAZIL

8.4.6.2.        MEXICO

8.4.6.3.        REST OF LATIN AMERICA

8.5. MIDDLE EAST AND AFRICA

8.5.1.    MARKET BY TYPE

8.5.2.    MARKET BY PRESCRIPTION

8.5.3.    MARKET BY THERAPEUTIC

8.5.4.    MARKET BY APPLICATION

8.5.5.    MARKET BY END-USER

8.5.6.    COUNTRY ANALYSIS

8.5.6.1.        UNITED ARAB EMIRATES

8.5.6.2.        SAUDI ARABIA

8.5.6.3.        TURKEY

8.5.6.4.        SOUTH AFRICA

8.5.6.5.        REST OF MIDDLE EAST & AFRICA

9.     COMPETITIVE LANDSCAPE

9.1. AKORN

9.2. ALLERGAN

9.3. APOTEX INC

9.4. BHARAT BIOTECH

9.5. CATALENT INC

9.6. CIPLA LIMITED

9.7. GLAXOSMITHKLINE

9.8. JOHNSON AND JOHNSON

9.9. NOVARTIS INTERNATIONAL AG

9.10.               PFIZER INC

9.11.               PROCTOR AND GAMBLE CO

9.12.               SANOTIZE RESEARCH AND DEVELOPMENT

9.13.               SUN PHARMACEUTICALS INDUSTRIES LTD

9.14.               TEVA PHARMACEUTICAL INDUSTRIES LTD

9.15.               VIATRIS

10. RESEARCH METHODOLOGY & SCOPE

10.1.               RESEARCH SCOPE & DELIVERABLES

10.2.               SOURCES OF DATA

10.3.               RESEARCH METHODOLOGY

 

 

TABLE LIST

 

TABLE 1: GLOBAL NASAL SPRAY MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: GLOBAL NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 5: GLOBAL NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: GLOBAL NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL NASAL SPRAY MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)

TABLE 9: NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 10: NORTH AMERICA NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 11: NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 12: NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 13: NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 14: NORTH AMERICA NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 15: EUROPE NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 16: EUROPE NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 17: EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 18: EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 19: EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 20: EUROPE NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 21: ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 22: ASIA-PACIFIC NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 23: ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 24: ASIA-PACIFIC NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 25: ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 26: ASIA-PACIFIC NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 27: LATIN AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 28: LATIN AMERICA NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 29: LATIN AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 30: LATIN AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 31: LATIN AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 32: LATIN AMERICA NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 33: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 34: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 35: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 36: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 37: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 38: MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

 

 

FIGURE LIST

 

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: GLOBAL NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: GLOBAL NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 4: GLOBAL NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 5: GLOBAL NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 6: GLOBAL NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)

FIGURE 7: GLOBAL NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)

FIGURE 10: GLOBAL NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 15: GLOBAL NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 21: GLOBAL NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)

FIGURE 24: GLOBAL NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)

FIGURE 25: GLOBAL NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 27: UNITED STATES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: CANADA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 29: UNITED KINGDOM NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 30: GERMANY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 31: FRANCE NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 32: SPAIN NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 33: ITALY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 34: RUSSIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 35: REST OF EUROPE NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 36: CHINA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 37: JAPAN NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 38: INDIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 39: SOUTH KOREA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 40: ASEAN COUNTRIES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 41: AUSTRALIA & NEW ZEALAND NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 42: REST OF ASIA-PACIFIC NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 43: BRAZIL NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 44: MEXICO NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 45: REST OF LATIN AMERICA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 46: UNITED ARAB EMIRATES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 47: SAUDI ARABIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 48: TURKEY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 49: SOUTH AFRICA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 50: REST OF MIDDLE EAST & AFRICA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

 

 

MARKET OUTLOOK

 

Triton Market Research’s report denotes that the global nasal spray market is forecasted to register growth at a CAGR of 8.47% from 2021 to 2028. 

Factors such as emerging intranasal vaccines for COVID-19, rising acceptance of self-administration of medication, and increasing use of nasal sprays are driving the progression of the studied market globally. Additionally, the application of nasal sprays in treating depression is creating numerous opportunities for the nasal spray market.

Conversely, complications due to the excess use of nasal sprays negatively impact the global market's overall development.

 

 

REGIONAL OUTLOOK

The global nasal spray market covers North America, Asia-Pacific, Latin America, Europe, Middle East and Africa regions. 

Globally, the Asia-Pacific is anticipated to witness the fastest growth in the nasal spray market over the estimated phase. In recent years, allergic diseases have surged significantly in the region due to extensive urbanization and rising environmental pollution. Besides, the more prevalent causes of respiratory morbidity are smoking, infection, and air pollution. Some of the major respiratory diseases include TB and occupational lung diseases. Such factors have influenced the adoption of nasal spray among the population, thereby driving the nasal spray market’s growth in the APAC region.

 

 

COMPETITIVE OUTLOOK

 

The well-known companies in the nasal spray market consist of Sun Pharmaceuticals Industries Ltd, Johnson and Johnson, Novartis International AG, Sanotize Research and Development, Bharat Biotech, Viatris, Akorn, GlaxoSmithKline, Proctor and Gamble Co, Pfizer Inc, Catalent Inc, Cipla Limited, Allergan, Apotex Inc, and Teva Pharmaceutical Industries Ltd.

Johnson and Johnson is involved in the R&D, manufacture, and sale of various products in the healthcare sector. Its business segment includes consumer, pharmaceutical, and medical devices. The pharmaceutical segment provides products relating to immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and metabolism. Moreover, the company has operations across various regions, including Europe, the Middle East and Africa, the Asia-Pacific, and Latin America. It is headquartered in New Jersey, the United States.

 

Get more insights into the Global Nasal Spray Market:

 

https://www.tritonmarketresearch.com/reports/nasal-spray-market

 

 

SEGMENTATION

1.     AKORN

2.     ALLERGAN

3.     APOTEX INC

4.     BHARAT BIOTECH

5.     CATALENT INC

6.     CIPLA LIMITED

7.     GLAXOSMITHKLINE

8.     JOHNSON AND JOHNSON

9.     NOVARTIS INTERNATIONAL AG

10. PFIZER INC

11. PROCTOR AND GAMBLE CO

12. SANOTIZE RESEARCH AND DEVELOPMENT

13. SUN PHARMACEUTICALS INDUSTRIES LTD

14. TEVA PHARMACEUTICAL INDUSTRIES LTD

15. VIATRIS